Search clinical trials for: Candidate-6

Total 2680 results

Pfizer

Completed

Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age

Pneumococcal Disease

United States
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older

Respiratory Syncytial Virus Immunization

United States, Australia, Puerto Rico
University of Southampton
University of Oxford; University of Bristol; Public Health Wales

Not yet recruiting

DIagnoSing Care hOme UTI Study (DISCO UTI)

Urinary Tract Infections
Oles Honchar Dnipro National University
SynthezAI Corp.

Recruiting

Study of the Effect of the Auditory Stimulation on Stuttering Symptoms in Patients With a Deficit of Spectral Power in the EEG Beta Frequency Band (ZOV)

Stuttering, Adult | Stammering

Ukraine
Pfizer

Completed

A Phase 2 Study to Learn About a Monovalent Pneumococcal Conjugate Candidate in Healthy Toddlers

Healthy Participants

Poland, Finland
Pierre Van Damme
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PA... and other collaborators

Completed

Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults (nOPV2M4a)

Poliomyelitis

Belgium
Pfizer

Recruiting

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults

Shingles | Human | Herpes Zoster Infection

United States
Pierre Van Damme
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PA... and other collaborators

Completed

A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates

Poliomyelitis

Belgium
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

Healthy Volunteers | Respiratory Syncytial Virus Infection | Human Metapneumovirus

United States, Puerto Rico
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults

Tuberculosis

Philippines
Imperial College London
Royal Free Hospital NHS Foundation Trust; Royal Surrey County Hospital NHS...

Completed

MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers (MIRABILE)

Pancreatic Cancer | Cholangiocarcinoma | Biliary Stricture | Gallstone Disease | Ampullary Cancer

United Kingdom
GlaxoSmithKline

Completed

Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Airway Obstruction

China
Rambam Health Care Campus

Unknown

Electronic Nose and Fetal Chromosomal Disorders

Detecting Abnormal Fetal Karyotype by the Electronic Nose
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older

Healthy Volunteers | Respiratory Syncytial Virus Infection

Australia, Dominican Republic, Honduras
Clover Biopharmaceuticals AUS Pty Ltd

Withdrawn

Safety and Immunogenicity of SCB-2019 in Children <18 Years of Age

COVID-19

Colombia
Eva Pharma
Veterinary Serum & Vaccine Research Institute (VSVRI), Egypt; The Supreme Council... and other collaborators

Recruiting

Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection (Sphinx)

COVID-19

Egypt
Clover Biopharmaceuticals AUS Pty Ltd

Withdrawn

Immunogenicity and Safety of Adjuvanted SCB-2020S Vaccines in Adults

COVID-19
Community Medical Center, Toms River, NJ

Completed

Bias Reduction in Academic Recruitment (BRIAR)

Education, Medical | Internship and Residency | Interview

United States
Marylyn Addo
Charite University, Berlin, Germany; University of Cologne; Ludwig-Maximilians... and other collaborators

Completed

Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S

MERS (Middle East Respiratory Syndrome)

Germany
Biomedizinische Forschungs gmbH
Medical University of Vienna

Completed

Amendment of rTSST-1 Variant Vaccine Phase 1 Clinical Trial

Sepsis | Toxic-Shock Syndrome
Biomedizinische Forschungs gmbH
Medical University of Vienna

Completed

rTSST-1 Variant Vaccine Phase 1 First-in-man Trail (rTSST-1)

Toxic Shock Syndrome | Vaccination; Sepsis

Austria
Clover Biopharmaceuticals AUS Pty Ltd

Recruiting

First-in-human Safety and Immunogenicity Study of SCB-1019 in Healthy Adults

Respiratory Syncytial Virus Infection

Australia
GlaxoSmithKline

Completed

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years

Influenza

Belgium
GlaxoSmithKline

Completed

Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults

Influenza

Belgium
GlaxoSmithKline

Completed

Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults

Herpes Simplex
GlaxoSmithKline
Corixa Corporation

Completed

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults

Tuberculosis (TB)

United States
Takeda

Completed

Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore

Dengue Fever

Singapore
GlaxoSmithKline

Completed

Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children

Influenza

Japan
GlaxoSmithKline

Completed

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above

Influenza

France, Spain, Germany, Russian Federation, Estonia, Sweden, Netherlands
GlaxoSmithKline

Withdrawn

A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine

Influenza

Brazil
GlaxoSmithKline

Completed

Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant

Prophylaxis Herpes Simplex

Belgium
University Medical Centre Maribor
Faculty of Medicine, University of Maribor

Completed

Genetics of Self-injurious Behaviour

Self-Injurious Behavior | Self Injurious Behavior Without Suicidal Intent
GlaxoSmithKline

Completed

Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region

Tuberculosis (TB) | Tuberculosis Vaccines

South Africa
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults

Meningitis, Meningococcal

Australia
Mibelle AG

Withdrawn

Prophylactic Effect of a CANDIDA Mouthwash, Containing the Curolox™ Peptide

Erosion of Teeth, Unspecified

Switzerland
GlaxoSmithKline

Completed

Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate

Influenza

Russian Federation, Germany, France, Greece, United Kingdom, Norway, Estonia
GlaxoSmithKline

Completed

Study to Evaluate an Influenza Vaccine Candidate

Influenza

Finland, Greece
GlaxoSmithKline

Completed

Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects

Prophylaxis for Herpes Simplex

Austria, Germany, Belgium, United States, Australia, Canada, Denmark, France, Puerto Rico, South Africa, Spain, Switzerland
Takeda

Completed

Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants

Dengue Fever

Philippines, Dominican Republic, Panama
GlaxoSmithKline
The PATH Malaria Vaccine Initiative (MVI)

Completed

Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in Children

Malaria

Nigeria
GlaxoSmithKline

Completed

Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children

Malaria

Gabon
Ichor Medical Systems Incorporated
US Army Medical Research Institute of Infectious Diseases

Completed

Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers

Venezuelan Equine Encephalitis Virus Infection

United States
ANRS, Emerging Infectious Diseases

Completed

Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers (VRI01)

HIV Infection

France
Zhejiang Clover Biopharmaceuticals, Inc.

Active, not recruiting

Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China

COVID-19

China
Virometix
Center of Vaccinology, Ghent, Belgium (CEVAC); Expert Clinical Services Organization...

Completed

Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus

Acute Bronchiolitis Due to Respiratory Syncytial Virus

Belgium
Matrivax Research and Development Corporation

Completed

Safety and Immunogenicity of Typhax, a Typhoid Vaccine

Typhoid Fever
Institut Pasteur
Coalition for Epidemic Preparedness Innovations; Themis Bioscience GmbH

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine (COVID-19-101)

COVID-19

Belgium, France
Molecular Partners AG

Terminated

First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors

Advanced Malignant Solid Tumor

Netherlands, France
IVI Bilbao
bTI Vitoria

Completed

Effect of Plasma Rich in Growth Factors on Semen Quality

Vascular Endothelial Growth Factor Overexpression

Spain
ACM Biolabs

Completed

Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.

SARS-CoV-2 Infection

Australia

Search clinical trials for: Candidate-6

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations